Crossmark

Comment on “Evaluating the Effectiveness and Safety of Evinacumab in Treating Hypercholesterolemia and Hypertriglyceridemia: A Systematic Review and Meta-analysis of Randomized Controlled Trials”

Crossref DOI link: https://doi.org/10.1007/s40256-025-00780-7

Published Online: 2026-01-04

Published Print: 2026-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ahmad, Eeman

Ahmed, Shahzaib

Khan, Iftikhar https://orcid.org/0009-0004-9579-011X
License Information

Text and Data Mining valid from 2026-01-04

Version of Record valid from 2026-01-04
More Information

Article History

Received: 16 September 2024

Accepted: 27 November 2025

First Online: 4 January 2026

Declarations

:

: No external funding was used in the preparation of this letter.

: EA, SA, and IK declare that they have no potential conflicts of interest that might be relevant to the contents of this letter.

: All authors participated in writing, reviewing and editing this letter.

: Data sharing not applicable to this letter.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

Document is current

Any future updates will be listed below